What is the recommended evaluation and management for inguinal lymphadenopathy, including the appropriate contrast‑enhanced CT imaging protocol and subsequent steps based on imaging findings?

Inguinal Lymphadenopathy: CT Imaging Protocol and Management Algorithm

For inguinal lymphadenopathy requiring CT evaluation, order contrast-enhanced CT of the pelvis with portovenous phase imaging; nodes with short-axis diameter >8.8 mm warrant tissue diagnosis via image-guided core biopsy before definitive treatment.

CT Imaging Protocol

• Contrast-enhanced CT of the pelvis in portovenous phase is the standard imaging approach for evaluating inguinal lymphadenopathy. 1
• Normal inguinal lymph nodes have a mean short-axis diameter of 5.4 mm, with 8.8 mm representing two standard deviations above the mean (upper limit of normal). 2
• Expect 4–20 inguinal nodes per patient bilaterally; normal nodes are typically oval-shaped and contain internal fat attenuation in 85% of superficial and 78% of deep nodes. 2

Critical Imaging Pitfalls to Avoid

• Varicose veins can mimic lymphadenopathy on routine portovenous-phase CT, showing similar radiodensity to enlarged nodes; if uncertain, obtain MRI to differentiate tortuous venous convolutes from true lymph nodes. 3
• CT has 85% sensitivity and 67% specificity for detecting pathologic inguinal nodes, with a 33% false-positive rate; tissue confirmation is mandatory before treatment. 1

Algorithmic Approach Based on Node Characteristics

Nodes ≤8.8 mm Short Axis

• Consider observation with clinical correlation if nodes are symmetric, oval, contain fat, and patient lacks systemic symptoms (fever, night sweats, weight loss). 4, 2
• If lymphadenopathy persists beyond 4 weeks or systemic symptoms are present, obtain complete blood count, C-reactive protein, ESR, and tuberculosis testing. 4

Nodes >8.8 mm Short Axis or Suspicious Features

• Nodes that are hard, matted/fused, or >2 cm in any dimension require tissue diagnosis regardless of imaging appearance. 4
• Obtain image-guided core biopsy of the most abnormal node before initiating any treatment. 5
• If initial core biopsy is negative but clinical suspicion remains high, perform repeat biopsy or surgical excision. 5

Context-Specific Considerations

When Malignancy is Suspected (Pelvic Primary, Melanoma, Penile Cancer)

• Perform whole-body staging with 18F-FDG PET-CT or contrast-enhanced CT of chest/abdomen/pelvis to exclude distant metastases. 5
• Approximately 50% of palpable inguinal nodes at initial cancer presentation are inflammatory; however, nodes appearing during follow-up are malignant in nearly 100% of cases. 5
• For penile cancer specifically, if dynamic sentinel node biopsy is unavailable, use inguinal ultrasound with fine-needle aspiration of sonographically abnormal nodes. 5

When Infection is Suspected

• Document duration, associated skin lesions, animal exposures, recent trauma, and travel history. 4, 6
• Antibiotics may be initiated empirically for bacterial lymphadenitis only after appropriate cultures are obtained. 4
• Avoid corticosteroids—they mask histologic diagnosis of lymphoma and other malignancies. 4

Key Clinical Pearls

• Epitrochlear or supraclavicular lymphadenopathy carries higher malignancy risk than inguinal nodes and demands aggressive workup. 4
• Inguinal lymphadenopathy in ovarian cancer may represent peritoneal surface spread along hernia tracks rather than hematogenous metastasis; complete cytoreduction is achievable with acceptable outcomes. 7
• Bilateral symmetric inguinal lymphadenopathy suggests systemic disease (infection, autoimmune, lymphoma), while unilateral or asymmetric nodes favor localized pathology (regional infection, metastasis). 4, 2